Nicotinamide adenine dinucleotide (NAD) levels decrease with aging as a result of aging-associated CD38 upregulation. Here, we established a cell model with decreased cellular NAD levels by overexpressing CD38 or treating cells with FK866, an inhibitor of nicotinamide phosphoribosyltransferase. We revealed that decreased NAD triggered reactive oxygen species (ROS)-mediated degradation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), which drove cells to undergo epithelial-mesenchymal transition (EMT). Moreover, we showed that oxidation of the Cys44 residue to sulfonic acid in 15-PGDH led to its degradation via non-canonical ubiquitination-proteasome and autophagy pathways. Mutation of Cys44 to alanine abolished ROS-induced 15-PGDH degradation. We demonstrated that 15-PGDH silencing promoted EMT, whereas supplementation with NAD precursors increased NAD and 15-PGDH stability, and reversed the EMT process. Taken together, these results suggest that declining NAD levels contribute to age-dependent increases in cancer incidence, and repletion of NAD precursors is beneficial for increasing 15-PGDH expression.
Pubmed ID: 29307841 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Genetic locus: PARP1 (human) mapping to 1q42.12.
View all literature mentionsThis polyclonal targets Vimentin
View all literature mentionsThis monoclonal targets Cytokeratin 18
View all literature mentionsThis monoclonal targets Human SirT1
View all literature mentionsThis polyclonal targets SQSTM1/p62
View all literature mentionsThis monoclonal targets N-Cadherin
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis monoclonal targets COX2 / Cyclooxygenase 2
View all literature mentionsThis monoclonal targets E Cadherin
View all literature mentionsThis polyclonal targets Anxa3
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis unknown targets Catenin, beta
View all literature mentions